Bruno Aouizerate
Overview
Explore the profile of Bruno Aouizerate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerentes M, Lajnef M, Szoke A, Aouizerate B, Berna F, Clery M, et al.
Drug Saf
. 2025 Mar;
PMID: 40088341
Background: The life expectancy of patients with schizophrenia is reduced, partly due to cardiovascular diseases. Antipsychotics are associated with QT interval prolongation, which is a risk factor for arrhythmia and...
2.
Samalin L, Godin O, Moisset X, Chalayer A, Pelletier A, Lefrere A, et al.
J Affect Disord
. 2025 Mar;
379:289-296.
PMID: 40081587
Introduction: Individuals with bipolar disorder (BD) frequently experience comorbid medical conditions, with migraine being among the most common. While research on migraine prevalence in BD is growing, the associated clinical...
3.
Barbosa S, Tamouza R, Leboyer M, Aouizerate B, Andrieu C, Andre M, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2025 Mar;
137:111304.
PMID: 40023308
Background: Schizophrenia (SZ) commonly manifests through multiple relapses, each impeding the path to recovery and incurring personal and societal costs. Despite the identification of various risk factors associated to the...
4.
Lefrere A, Godin O, Jamain S, Dansou Y, Samalin L, Alda M, et al.
Biol Psychiatry
. 2024 Oct;
PMID: 39395474
Background: Bipolar disorder (BD) is a complex and heterogeneous psychiatric disorder. It has been suggested that neurodevelopmental factors contribute to the etiology of BD, but a specific neurodevelopmental phenotype (NDP)...
5.
Zachos K, Godin O, Choi J, Jung J, Aouizerate B, Aubin V, et al.
J Affect Disord
. 2024 Aug;
364:167-177.
PMID: 39117002
Background: Nutrition is largely affected in bipolar disorder (BD), however, there is a lack of understanding on the relationship between dietary categories, BD, and the prevalence of metabolic syndrome. The...
6.
Zachos K, Choi J, Godin O, Chernega T, Kwak H, Jung J, et al.
Psychiatry Res
. 2024 Jul;
339:116063.
PMID: 39003800
The object of this study is test whether mitochondrial blood-based biomarkers are associated with markers of metabolic syndrome in bipolar disorder, hypothesizing higher lactate but unchanged cell-free circulating mitochondrial DNA...
7.
Yrondi A, Blanc O, Anguill L, Arbus C, Boudieu L, Patoz M, et al.
BMC Psychiatry
. 2024 Jul;
24(1):487.
PMID: 38961386
Objectives: Electroconvulsive therapy (ECT) is one of the most effective treatments in mood disorders, mainly in major depressive episode (MDE) in the context of either unipolar (MDD) or bipolar disorder...
8.
Herbein M, Barbosa S, Collet O, Khalfallah O, Navarro M, Bailhache M, et al.
Brain Behav Immun Health
. 2024 Apr;
38:100768.
PMID: 38586283
There is growing evidence that imbalance immune activity plays a role in the development of neurodevelopmental and psychiatric disorders in children. Mood dysregulation (MD) is a debilitating transnosographic syndrome whose...
9.
Spano L, Marie-Claire C, Godin O, Lebras A, Courtin C, Laplanche J, et al.
Transl Psychiatry
. 2024 Mar;
14(1):131.
PMID: 38429270
Bipolar disorder (BD) has been associated with premature cellular aging with shortened telomere length (TL) as compared to the general population. We recently identified a subgroup of young individuals with...
10.
Yrondi A, Javelot H, Nobile B, Boudieu L, Aouizerate B, Llorca P, et al.
Encephale
. 2024 Feb;
51(1):26-38.
PMID: 38369426
Introduction: The purpose of this update is to add newly approved nomenclatures and treatments as well as treatments yet to be approved in major depressive disorder, thus expanding the discussions...